People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other Health Care, Biotechnology, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Proteus Biomedical Inc | — | Other Health Care | Series D+ | $162.4M | $2.7B | 2009 |
| Calypso Medical Technologies Inc | — | Other Health Care | Series C | $69.5M | $171.5M | 2009 |
| Barosense Inc | — | Biotechnology | Series B | $56.9M | $1.2B | 2009 |
| Chrono Therapeutics Inc. | — | Other Health Care | Series B | $51.4M | $833.2M | 2014 |
| Gen1E Lifesciences Inc. | — | Biotechnology | Series B | $22.5M | $22.5M | 2025 |
| Tasso Inc. | — | Other | Series B | $17.0M | $282.5M | 2019 |
| Cinchcast, Inc | — | Other Technology | Series A | $9.2M | $34.7M | 2010 |
Alan Levy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alan Levy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| PAUL CONLEY | 1 | 17 |
| David Gill | 1 | 8 |
| John Freund | 1 | 7 |
| Michael Sweeney | 1 | 7 |
| Ross Jaffe | 1 | 7 |
| Jeanne Cunicelli | 1 | 7 |
| Ryan Schwarz | 1 | 7 |
| Terry Gould | 1 | 6 |
| Immanuel Thangaraj | 1 | 6 |
| Alan Frazier | 1 | 5 |
| Frank Fischer | 1 | 5 |
| Richard Perlman | 1 | 4 |
| Richard Shorten | 1 | 4 |
| John Onopchenko | 1 | 4 |
| Todd Thompson | 1 | 4 |
| Eric Linsley | 1 | 4 |
| Andrew Thompson | 1 | 3 |
| Alan Levy, Ph.D. | 1 | 3 |
| Eric Meier | 1 | 3 |
| JAMES W. YOUNG | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.